Sana Biotechnology, Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating items
Research & Development 99.59M132.94M248.63M
Selling, General & Administrative 21.78M28.27M50.41M
Other Operating Expenses 19.78M124.94M57.87M
Operating Expenses 141.15M286.15M356.91M
Operating Income -141.15M-286.15M-356.91M
EBIT -141.15M-286.15M-356.91M
Non-operating items
Interest & Investment Income 2.86M0.75M0.68M
Other Non Operating Income -0.03M0.10M0.30M
Non Operating Income -0.03M0.10M0.30M
Net income details
EBT -138.32M-285.31M-355.93M
Tax Provisions -7.55M
Profit After Tax -130.78M-285.31M-355.93M
Income from Continuing Operations -130.78M-285.31M-355.93M
Consolidated Net Income -130.78M-285.31M-355.93M
Income towards Parent Company -130.78M-285.31M-355.93M
Net Income towards Common Stockholders -130.78M-285.31M-355.93M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 182.31M182.31M188.83M190.73M197.13M223.27M
EBITDA -141.15M-286.15M-356.91M
Tax Rate 5.46%